“…Antiandrogens, or androgen receptor blockers, competitively inhibit the binding of dihydrotestosterone to its receptor (21) and include cyproterone acetate (CPA), drospirenone, spironolactone, and flutamide. Use of antiandrogens is contraindicated in men because they result in feminization and in women during pregnancy as they can feminize a male fetus (15).…”